Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

CLL - 160

Real-World Treatment and Survival Outcomes for Zanubrutinib and Acalabrutinib Monotherapy Among Treatment-Naive Patients With Chronic Lymphocytic Leukemia in the United States

Preview of Real-World Treatment and Survival Outcomes for Zanubrutinib and Acalabrutinib Monotherapy Among Treatment-Naive Patients With Chronic Lymphocytic Leukemia in the United States

View Poster Contact Presenter

Poster Presenter

Daniel A. Ermann

Authors

Daniel A. Ermann

Part of Topic

Chronic Lymphocytic Leukemia (CLL)

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.